109.34
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$107.24
Offen:
$107.12
24-Stunden-Volumen:
1.08M
Relative Volume:
1.15
Marktkapitalisierung:
$7.72B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
10.18
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
+1.13%
1M Leistung:
-3.94%
6M Leistung:
-24.37%
1J Leistung:
-38.05%
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DVA
Davita Inc
|
109.34 | 7.57B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
488.27 | 110.11B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
189.28 | 16.65B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.70 | 13.05B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
201.26 | 12.50B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
171.66 | 9.85B | 4.11B | 239.98M | 193.10M | 4.12 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Q4 2025 earnings preview - MSN
Can Operational Execution Support DaVita's Q4 Performance? - Nasdaq
Uncovering Potential: DaVita's Earnings Preview - Benzinga
A Piece Of The Puzzle Missing From DaVita Inc.'s (NYSE:DVA) Share Price - 富途牛牛
DaVita Inc. (DVA) Investor Outlook: Unpacking a 32% Potential Upside Amidst Healthcare Challenges - DirectorsTalk Interviews
Assessing DaVita (DVA) Valuation As Earnings Growth Optimism Builds Ahead Of Quarterly Results - Yahoo Finance
Portfolio Update: Does DaVita Inc have a competitive edgeJuly 2025 Earnings & Step-by-Step Swing Trade Plans - baoquankhu1.vn
DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know - Yahoo Finance
DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call - Yahoo Finance
149,584 Shares in DaVita Inc. $DVA Acquired by Rakuten Investment Management Inc. - MarketBeat
DaVitaIn the Sweet Spot of Growth and Value - Investing.com
DaVita’s Stock Looks Cheap, But The Risks Are Real - Finimize
Opt-In Forms In DaVita Wage Suit Need Revision, Judge Says - Law360
Lobbying Update: $1,110,000 of DAVITA INC lobbying was just disclosed - Quiver Quantitative
Here's Why You Should Hold DaVita Stock in Your Portfolio for Now - Finviz
Quarterly Trades: Can DaVita Inc continue delivering strong returnsWeekly Market Outlook & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Sumitomo Mitsui Trust Group Inc. Has $13.05 Million Holdings in DaVita Inc. $DVA - MarketBeat
Campbell & CO Investment Adviser LLC Sells 14,681 Shares of DaVita Inc. $DVA - MarketBeat
Here's what to expect from DaVita's next earnings report - MSN
Is DaVita (DVA) Pricing In Its Recent 37% One Year Share Price Gain? - Yahoo Finance
Is DaVita’s (DVA) Community Health Push Reframing Its Balance Between Patient Impact and Profitability? - Yahoo Finance
FOMO Trade: Does DaVita Inc have strong fundamentalsMarket Activity Report & Verified Trade Idea Suggestions - baoquankhu1.vn
Here's What to Expect From DaVita's Next Earnings Report - Barchart.com
Is DaVita’s (DVA) Community Health Push Reframing Its Role In Long-Term Care Management? - Sahm
Behind Berkshire’s Curtain: Is Greg Abel Preparing to Cut Davita Loose? - Yahoo Finance
Davita stock hits 52-week low at $108.37 By Investing.com - Investing.com Nigeria
DaVita Inc (DVA) Trading Down 3.83% on Jan 13 - GuruFocus
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita (NYSE:DVA) Reaches New 1-Year LowHere's What Happened - MarketBeat
Davita stock hits 52-week low at $108.37 - Investing.com
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Exploring the 28% Potential Upside in Healthcare’s Dialysis Leader - DirectorsTalk Interviews
DaVita Inc. (NYSE:DVA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
SG Americas Securities LLC Has $5.96 Million Stock Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc.: How a Dialysis Giant Is Quietly Re?Engineering Kidney Care - AD HOC NEWS
The Truth About DaVita Inc.: Why Wall Street Is Watching While TikTok Sleeps On It - AD HOC NEWS
DaVita Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Assessing DaVita (DVA) Valuation After Recent Share Price Weakness - Yahoo Finance
Will DaVita Inc. stock deliver compounding returns2025 Sector Review & Risk Controlled Stock Alerts - ulpravda.ru
Bank Watch: What downside risks could hit DaVita Inc. stockMarket Growth Report & Capital Protection Trade Alerts - Улправда
Is DaVita Inc. stock a top momentum playMarket Growth Report & Weekly Setup with High ROI Potential - ulpravda.ru
Is DaVita Inc. stock ready for breakout2025 Momentum Check & Safe Entry Point Identification - ulpravda.ru
National Branding Achieves Milestone of Over 1,700 Sign Projects with DaVita Kidney Care Using Sign and Branding Management Software - USA Today
How DaVita Inc. stock reacts to oil pricesMarket Volume Summary & Fast Moving Stock Trade Plans - ulpravda.ru
Will DaVita Inc. stock gain from strong economy2025 Earnings Surprises & Free AI Powered Buy and Sell Recommendations - Улправда
What technical signals suggest for DaVita Inc. stockJuly 2025 Earnings & Fast Entry Momentum Trade Alerts - ulpravda.ru
Will DaVita Inc. stock rally after Fed decisionsPortfolio Update Report & AI Powered Buy and Sell Recommendations - Улправда
What dividend safety rating applies to DaVita Inc. (TRL) stockEarnings Growth Summary & Verified Entry Point Detection - Улправда
Why DaVita HealthCare (DVA) Dipped More Than Broader Market Today - Yahoo Finance
Is DaVita stock underperforming the Dow? - MSN
DaVita (NYSE:DVA) Reaches New 1-Year Low After Analyst Downgrade - MarketBeat
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):